Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 601 | $4.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 602 | $4.41M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 603 | $4.41M | Healthcare | Medical Devices | United States | Nasdaq |
| 604 | $4.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 605 | $4.40M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 606 | $4.36M | Healthcare | Biotechnology | United States | Nasdaq |
| 607 | $4.12M | Healthcare | Biotechnology | United States | Nasdaq |
| 608 | $4.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 609 | $3.99M | Healthcare | Medical Devices | United States | Nasdaq |
| 610 | $3.92M | Healthcare | Medical Devices | United States | Nasdaq |
| 611 | $3.92M | Healthcare | Medical Devices | United States | Nasdaq |
| 612 | $3.86M | Healthcare | Pharmaceuticals | United States | NYSE |
| 613 | $3.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 614 | $3.78M | Healthcare | Medical Devices | United States | Nasdaq |
| 615 | $3.65M | Healthcare | Medical Devices | United States | Nasdaq |
| 616 | $3.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 617 | $3.59M | Healthcare | Medical Devices | United States | Nasdaq |
| 618 | $3.53M | Healthcare | Biotechnology | United States | Nasdaq |
| 619 | $3.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 620 | $3.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 621 | $3.46M | Healthcare | Medical Devices | United States | Nasdaq |
| 622 | $3.43M | Healthcare | Pharmaceuticals | United States | NYSE |
| 623 | $3.42M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 624 | $3.33M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 625 | $3.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 626 | $3.22M | Healthcare | Biotechnology | United States | Nasdaq |
| 627 | $3.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 628 | $3.08M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 629 | $2.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 630 | $2.84M | Healthcare | Medical Devices | United States | Nasdaq |
| 631 | $2.83M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 632 | $2.80M | Healthcare | Diagnostics & Research | United States | NYSE |
| 633 | $2.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 634 | $2.64M | Healthcare | Medical Devices | United States | NYSE |
| 635 | $2.63M | Healthcare | Pharmaceuticals | United States | NYSE |
| 636 | $2.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 637 | $2.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 638 | $2.37M | Healthcare | Medical Devices | — | Nasdaq |
| 639 | $2.23M | Healthcare | Biotechnology | United States | Nasdaq |
| 640 | $2.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 641 | $2.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 642 | $2.05M | Healthcare | Medical Devices | United States | Nasdaq |
| 643 | $1.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 644 | $1.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 645 | $1.97M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 646 | $1.77M | Healthcare | Medical Devices | United States | Nasdaq |
| 647 | $1.74M | Healthcare | Medical Devices | United States | Nasdaq |
| 648 | $1.68M | Healthcare | Medical Devices | United States | Nasdaq |
| 649 | $1.67M | Healthcare | Biotechnology | United States | Nasdaq |
| 650 | $1.44M | Healthcare | Medical Devices | United States | Nasdaq |
| 651 | $1.43M | Healthcare | Biotechnology | United States | Nasdaq |
| 652 | $1.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 653 | $1.31M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 654 | $1.23M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 655 | $1.12M | Healthcare | Medical Devices | United States | Nasdaq |
| 656 | $1.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 657 | $1.00M | Healthcare | Medical Devices | United States | Nasdaq |
| 658 | $1.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 659 | $0.96M | Healthcare | Medical Devices | United States | NYSE |
| 660 | $0.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 661 | $0.76M | Healthcare | Pharmaceuticals | United States | NYSE |
| 662 | $0.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 663 | $0.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 664 | $0.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 665 | $0.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 666 | $0.64M | Healthcare | Medical Devices | United States | NYSE |
| 667 | $0.57M | Healthcare | Biotechnology | United States | Nasdaq |
| 668 | $0.51M | Healthcare | Healthcare Providers | United States | NYSE |
| 669 | $0.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 670 | $0.36M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 671 | $0.33M | Healthcare | Pharmaceuticals | United States | NYSE |
| 672 | $0.31M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 673 | $0.30M | Healthcare | Pharmaceuticals | United States | NYSE |
| 674 | $0.28M | Healthcare | Pharmaceuticals | United States | NYSE |
| 675 | $0.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 676 | $0.23M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 677 | $0.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 678 | $0.19M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 679 | $0.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 680 | $0.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 681 | $0.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 682 | $0.04M | Healthcare | Medical Devices | United States | NYSE |
| 683 | $0.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 684 | $0.03M | Healthcare | Diagnostics & Research | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 684 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.